欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EE/H/0189/001
药品名称
Cilozek
活性成分
Cilostazol 50.0 mg
剂型
Tablet
上市许可持有人
Adamed Pharma S.A. Pieńków, ul. M. Adamkiewicza 6A 05-152 Czosnów Poola
参考成员国 - 产品名称
Estonia (EE)
CILOZEK
互认成员国 - 产品名称
Greece (GR)
CILOSTAZOL/ADAMED
Poland (PL)
Cilozek
Hungary (HU)
CILOZEK 50 mg tabletta
许可日期
2014/02/09
最近更新日期
2025/01/31
药物ATC编码
B01AC23 cilostazol
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_spc_2
Date of last change:2024/09/06
Final Labelling
|
LAB_EE_189_001_clean
Date of last change:2024/09/06
Final PL
|
PIL_EE_189_001_clean
Date of last change:2024/09/06
PubAR
|
PublicAR_cilozek
Date of last change:2024/09/06
Final SPC
|
SPC_EE_189_001_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase